If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

It gets tricky fast': benefits lawyer outlines legal pitfalls of HR offering – or not offering – weight loss drugs in Canada ...

Popular medications approved for weight loss, diabetes, and heart disease may have health benefits beyond weight loss, and blood sugar control, but there are risks too.

Oikos and its other popular brands are seeing a spike in demand as people taking the weight-loss medications turn to the portion-controlled snacks to meet their nutritional needs.

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...

Several years ago, a little-known drug named Ozempic - previously used only to treat diabetes - emerged as a promising new drug for weight ...

With a strategic focus on innovation and a robust operational framework, Medifast is well-placed for growth in the weight loss and GLP-1 medication space.

GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...